Source:Journal of Allergy and Clinical Immunology
Author(s): Mark A. Blankestijn, Niels W.C.J. van de Donk, Kate Sasser, André C. Knulst, Henny G. Otten
In the management of allergic diseases, targeting IgE using biologicals is a current research focus. This proof of concept shows that plasma cell depletion using daratumumab results in decreased total and allergen-specific IgE levels.
http://ift.tt/2iNsKtc
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου